A Phase lll, Randomized, Controlled Investiagtion of Six Weeks vs. Six Months of Oral Valganciclovir Therapy in Infants with Symptomatic Congenital Cytomegalovirus Infection (CASG 112) Version 2.0.
|Effective start/end date||8/15/08 → 7/31/13|
- THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
- NATIONAL INSTITUTES OF HEALTH (NIH)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.